CHARACTERIZATION OF NATURALLY-OCCURRING AUTOANTIBODIES AGAINST TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) - IN-VITRO FUNCTION AND PRECISE EPITOPE MAPPING BY PHAGE EPITOPE LIBRARY
M. Sioud et al., CHARACTERIZATION OF NATURALLY-OCCURRING AUTOANTIBODIES AGAINST TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) - IN-VITRO FUNCTION AND PRECISE EPITOPE MAPPING BY PHAGE EPITOPE LIBRARY, Clinical and experimental immunology, 98(3), 1994, pp. 520-525
Naturally occurring autoantibodies against cytokines exist in the sera
of patients with autoimmune diseases as well as in the sera of normal
individuals. We report here that affinity-purified autoantibodies aga
inst human TNF-alpha from one rheumatoid arthritis (RA) patient inhibi
ted the cytotoxic effect of TNF-alpha on the mouse fibrosarcoma cell l
ine WEHI 164, by 50%. In an attempt to predict the autoantibodies' rec
ognition site on TNF-alpha protein we screened a random nanopeptide ph
age library with the affinity-purified TNF-alpha autoantibodies. Among
63 random selected clones, 46 clones carried the sequence ASSLLASSP,
NSSPYLNTK or PQSPGSSFP. Frequency analysis of the relative occurrence
of the 20 amino acids in the nanopeptides displayed by 50 random bacte
riophages picked before selection and 63 after selection to bind to TN
F-alpha autoantibodies indicated that proline (P < 0.0003) and serine
(P < 0.04) are involved in the binding of the autoantibodies to the ph
ages. Furthermore, we demonstrated that three synthetic peptides (ASSL
LASSP, NSSPYLNTK and PPLKPVIDE) displayed by the selected phages reduc
ed the binding of the autoantibodies to TNF-alpha protein by 50%. Inte
restingly, the sera of mice (BALB/c) immunized with phages displaying
ASSLLASSP and NSSPYLNTK peptide showed an anti-TNF-alpha response as d
etected by ELISA. This response was not found in mice immunized with t
he wild type phage. Thus, the recombinant phages selected from the pha
ge libraries could be used as carrier for immunization, and therefore
as a tool for vaccine development. This work sets the stage for experi
ments designed to isolate ligands for protective antibodies.